Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
British Journal of Cancer|June 30, 2011
Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistanceJ N Jeyapalan, D A Mohamed Noor, S-H Lee, et al.Neuro-Oncology|January 12, 2022
SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium StudyTimothy A Ritzmann, Rebecca J Chapman, John-Paul Kilday, et al.Plos One|June 16, 2017
Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratificationFelipe Andreiuolo, Gwénaël Le Teuff, Mohamed Amine Bayar, et al.Neuro-Oncology|December 18, 2020
Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institutionClaire Forde, Andrew T King, Scott A Rutherford, et al.Journal of Medical Genetics|June 25, 2015
Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2Stavros M Stivaros, Anat O Stemmer-Rachamimov, Robert Alston, et al.Neuro-Oncology|March 14, 2023
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA studyRebecca J Chapman, David R Ghasemi, Felipe Andreiuolo, et al.Neuro-Oncology|October 14, 2022
A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomesKatherine Green, Paraskevi Panagopoulou, Felice D'Arco, et al.Neuro-Oncology Advances|April 13, 2023
Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progressionD Gareth Evans, Dorothy Halliday, Rupert Obholzer, et al.Frontiers in Oncology|February 15, 2024
PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adultsNicola Fenwick, Rebekah Weston, Keith Wheatley, et al.Ecancermedicalscience|April 26, 2016
Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain TumoursAudrey Nailor, David A Walker, Thomas S Jacques, et al.Pageof 11